Businessweek Archives

Jan Leschly


Cover Story -- The Best Managers: Top Managers of 1995

JAN LESCHLY

JAN LESCHLY, CEO of Anglo-American drugmaker SmithKline Beecham, spent 1995 digesting $5 billion in acquisitions of managed-care and consumer-medicine markets, then turned his attention to heartburn--by managing the transition of ulcer drug Tagamet, once the world's largest-selling drug, to over-the-counter. SKB's sales could hit $10 billion in '95.Return to top

Return to top


Too Cool for Crisis Management
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus